Chiome Bioscience Inc. announced non-consolidated earnings results for the Three months ended Mar. 31, 2021. For the period, the company reported net sales of JPY 246 million against JPY 90 million for the same period last year. Operating loss was JPY 155 million against JPY 426 million for the same period last year. Net loss was JPY 160 million against JPY 425 million for the same period last year. Net loss per share was JPY 4 against JPY 12.78 for the same period last year.